Trim CRM to 55% weight at resistance; deploy $185 puts, stop $212, reload at $185/$178
This is a trim, not an exit — $16.5B TTM FCF and moats support long-term ownership. However, the ~70% buyback-driven EPS composition, MACD exhaustion at $209-210 resistance, and $30B fresh debt burden constrain the easy-money phase. Execute trim to 55% now into current strength ($205-210), deploy $185 puts immediately, stop at $212, and reload in two tranches at $185 and $178 with hard floor at $173. Cap at 1.5% risk capital until consolidation resolves with either breakout above $213.5 or pullback to reload zones.
| Position | Action |
|---|---|
| Current overweight above 70% benchmark weight | Trim to 55% benchmark weight (mid-range structural median) |
| Stop-loss trigger | Exit at $212 close (between $209-210 resistance and $213.5 Bollinger upper) |
| First reload zone | Reload tranche 1 at $185 strike |
| Second reload zone | Reload tranche 2 at $178 strike |
| Hard floor breach | Hard floor at $173 (below 50 SMA) |
| Position size cap | Cap residual at 1.5% of risk capital until breakout above $213.5 on volume resolves |
Salesforce has successfully pivoted from "growth-at-all-costs SaaS incumbent" to "AI-native enterprise platform with reaccelerating revenue, expanding margins, fortress-level free cash flow, and a unique strategic moat" — and the market is just starting to reprice this transformation.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 202.67 | bullish |
| 50 SMA | 177.06 | bullish |
| 200 SMA | 199.46 | neutral |
| MACD Line | 8.24 | bullish |
| MACD Signal | 7.84 | bullish |
| MACD Histogram | 0.40 | bearish |
| RSI (14) | 62.31 | bullish |
| ATR (14) | 7.71 | neutral |
| Bollinger Upper Band | 213.5 | bearish |
| Bollinger Middle Band | 196.4 | neutral |
| Bollinger Lower Band | 179.3 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Pullback to $185 zone
Then: Execute tranche 1 reload at $185
Salesforce's AI partnership with Anthropic transforms the AI-disruption threat into a distribution advantage
↩ rebuts: “Bear claim that AI will disintermediate Salesforce's front-end”
EV: +53% · concedes: The 200 SMA is still declining — long-term trend confirmation is incomplete; Revenue beat was marginal at only +0.25%; Goodwill of $59B from Slack, Tableau, and MuleSoft creates theoretical impairment risk; Pullback to $199-$203 zone is possible before resuming higher
The Q2 print was a financially-engineered beat built on $37B of buybacks and $24.8B of fresh debt — not on operational acceleration — and the stock is now trading into a major overhead resistance zone ($209–$210) that already failed once in June, with momentum, valuation, and sector context all flashing warning signs that the bulls refuse to acknowledge.
EV: -15% to -25% over 90 days (targets: $199/$185/$165 vs. entry at $207-$212) · concedes: FCF remains substantial at $13B adjusted; coverage is still adequate in base case; Good business with strong competitive position; Multiple AI partnerships provide some distribution optionality
→ vs conservative: Forward P/E of 13.3x is a mirage; approximately 70% of the implied 80% EPS growth rate is share count arithmetic from buybacks, not operational performance; net debt rose from roughly zero to 30.4B on 30B debt issuance, making EPS accretion a leverage story not a margin story
→ vs conservative: FCF yield of 9.8% and 38.6% FCF margin are real but distorted by 1.3B annual debt service obligation that will constrain future buyback capacity; the buyback treadmill is approaching its speed limit
→ vs neutral: Waiting for confirmation after a 33% rally in 30 days with coiled volatility at resistance means the neutral analyst will buy 5-10% lower after the setup rolls over, not before; ATR compressing to 7.71 from 9.30 indicates imminent volatility expansion
→ vs neutral: The neutral analyst's own technical report concludes avoid chasing at 205+ with unfavorable risk-reward, which is an internal contradiction that supports trimming at current levels rather than holding
| bullish |
Support: 202.7 · 199.5 · 196.4 · 179.3 | Resistance: 209 · 210 · 213.5
CRM shows a cautiously bullish setup with price above all moving averages and MACD/RSI in constructive territory, but momentum is decelerating (narrowing MACD histogram) and the 200 SMA remains in a long-term decline. The overall recommendation is HOLD with tactical entries favored on pullbacks to the 10 EMA/200 SMA zone (~$199–203) rather than chasing at current levels near 205. A decisive breakout above $210 on volume or a pullback entry offers the best risk/reward.
Market Capitalization
$168.4B
Stock Price (Implied)
~$205.6
52-Week High
$269.11
52-Week Low
$146.32
50-Day Moving Average
$176.24
200-Day Moving Average
$200.36
Beta
1.152
Dividend Yield
0.86%
Revenue Q1 FY27
$11.13B
Revenue YoY Growth Q1 FY27
~13.3%
Revenue TTM
$42.83B
Gross Profit Q1 FY27
$8.56B
Gross Margin Q1 FY27
76.9%
Gross Margin TTM
~77.6%
Operating Income Q1 FY27
$2.43B
Operating Margin Q1 FY27
21.8%
Operating Margin TTM
21.8%
Net Income Q1 FY27
$2.11B
Net Income TTM
$8.02B
Profit Margin TTM
18.7%
Diluted EPS Q1 FY27
$2.42
Diluted EPS TTM
$8.64
Diluted Shares Q1 FY27
871M
EBITDA TTM
$12.89B
EBITDA Margin TTM
~30.1%
FCF Q1 FY27
$6.56B
FCF TTM
$16.55B
FCF Margin
~38.6%
CapEx Q1 FY27
-$0.145B
SBC Quarterly
~$850M–$1.1B
Cash & Equivalents
$8.94B
Short-term Investments
$2.90B
Total Liquidity
~$11.8B
Total Debt
$41.88B
Net Debt
$30.35B
Stockholders' Equity
$34.24B
Working Capital
-$5.89B
Current Ratio
0.79
Debt/Equity
124.3%
Goodwill
$59.3B
Goodwill & Intangibles
$65.9B
Tangible Book Value
-$31.7B
Treasury Stock
$55.0B
Buybacks TTM
~$37.2B
Dividends TTM
~$1.6B
M&A TTM
~$10.7B
Q1 FY27 Buyback
$27.25B
New Debt Issued Q1 FY27
~$24.8B
Interest Expense Annualized
~$1.3B
P/E TTM
23.8x
Forward P/E
13.3x
Forward EPS
$15.52
Implied EPS Growth
~80%
PEG Ratio
0.85
P/B
4.92x
EV/EBITDA (approx)
~13.6x
FCF Yield
~9.8%
Return on Equity
16.9%
Return on Assets
5.7%
R&D as % of Revenue
~14.6%
Revenue Q4 FY26
$11.20B
Revenue Q3 FY26
$10.26B
Revenue Q2 FY26
$10.24B
Revenue Q1 FY26
$9.83B
Gross Margin Q4 FY26
77.6%
Gross Margin Q3 FY26
78.0%
Gross Margin Q2 FY26
78.1%
Operating Income Q4 FY26
$2.16B
Operating Income Q3 FY26
$2.45B
Operating Income Q2 FY26
$2.34B
Operating Income Q1 FY26
$1.98B
Net Income Q4 FY26
$1.94B
Net Income Q3 FY26
$2.09B
Net Income Q2 FY26
$1.89B
Net Income Q1 FY26
$1.54B
Diluted EPS Q4 FY26
$2.07
Diluted EPS Q3 FY26
$2.19
Diluted EPS Q2 FY26
$1.96
Diluted EPS Q1 FY26
$1.59
FCF Q4 FY26
$5.32B
FCF Q3 FY26
$2.18B
FCF Q2 FY26
$0.61B
FCF Q1 FY26
$6.30B
OCF Q1 FY27
$6.70B
OCF Q4 FY26
$5.46B
OCF Q3 FY26
$2.32B
OCF Q2 FY26
$0.74B
OCF Q1 FY26
$6.48B
Total Assets
$106.7B
Strengths
Concerns
Salesforce is undergoing a fundamental transformation from growth-at-all-costs to disciplined profitability, with Q1 FY27 showing reaccelerating revenue growth (~13.3% YoY) and expanding GAAP operating margins (~22%), while generating $16.55B in trailing twelve-month free cash flow (38.6% margin). The company has pivoted to aggressive capital return through ~$37B in buybacks over the past year, funded by ~$24.8B in new debt issuance, which has pushed net debt to $30.35B and tangible book value negative—introducing meaningful leverage risk into an otherwise robust cash-generation story. The stock appears attractively valued on forward metrics (13.3x forward P/E, 0.85 PEG ratio) but requires continued AI product momentum and margin expansion to justify the elevated risk profile heading into Q2 FY27 earnings.
Macro: Prediction markets price an 87% probability of zero Fed rate cuts in 2026 (up 2.1pp WoW) and only an 8% probability of US recession by end-2026 (up 0.5pp WoW) — a 'higher-for-longer rates, but no landing' regime. July PCE came in firmer than expected on Aug. 26, consistent with the hawkish hold base case and explaining gold's pullback and equities drift into the open. Macro tail-risk is historically muted (8% recession odds), which is constructive for software cash flows but caps multiple expansion absent an earnings re-rating. The path to CRM outperformance is EPS compounding rather than multiple expansion.